Bankstown Hospital - Grand Rounds - Further Reading

Welcome to the Grand Rounds Further Reading List, Cardiology edition, brought to you by the Clinical Library, on Level 4, next to the Auditorium.

This library guide is to help support you in your professional development. Please give us feedback so we can improve this list in the future.

If you have any questions, please contact the Clinical Library on 9722 8250 or email SWSLHD-BankstownLibrary@health.nsw.gov.au or visit us Monday to Fridays, 8.30am - 5.00pm. (closed Wednesday afternoons from 1.00pm to 5.00pm)

Dobson, R., et al. (2021). "BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab." JACC: CardioOncology 3(1): 1-16  https://www.jacc.org/doi/abs/10.1016/j.jaccao.2021.01.011.

Quintana, R. A., et al. (2020). "Speckle-Tracking Echocardiography in Cardio-Oncology and Beyond." Texas Heart Institute Journal 47(2): 96-107  https://doi.org/10.14503/THIJ-18-6736

Speckle-tracking echocardiography has enabled clinicians to detect changes in myocardial function with more sensitivity than that afforded by traditional diastolic and systolic functional measurements, including left ventricular ejection fraction. Speckle-tracking echocardiography enables evaluation of myocardial strain in terms of strain (percent change in length of a myocardial segment relative to its length at baseline) and strain rate (strain per unit of time). Both measurements have potential for use in diagnosing and monitoring the cardiovascular side effects of cancer therapy. Regional and global strain measurements can independently predict outcomes not only in patients who experience cardiovascular complications of cancer and cancer therapy, but also in patients with a variety of other clinical conditions. This review and case series examine the clinical applications and overall usefulness of speckle-tracking echocardiography in cardio-oncology and, more broadly, in clinical cardiology.

Tan, L.-L. and A. R. Lyon (2021). "Cardio-oncology for the general cardiologist." Heart 107(15): 1254-1266  https://heart.bmj.com/content/heartjnl/107/15/1254.full.pdf

Negishi, T., et al. (2019). "Echocardiography and Cardio-Oncology." Heart, Lung and Circulation 28(9): 1331-1338  https://www.sciencedirect.com/science/article/pii/S1443950619305827.
    Owing to the ongoing increase in cancer survivors because of the remarkable and continuous progress in cancer management, a paradigm shift is occurring from cancer as a ‘terminal illness’ to a ‘chronic condition’ with cardiovascular risks. This also affects cardiology practice with increased cardiovascular morbidity and mortality rates among patients with cancer due to direct and/or indirect side effects of anticancer treatment. Thus, cardio-oncology has emerged as a new cardiology subspecialty, which focusses on risk stratification, prevention, diagnosis, treatment, and follow-up of cardiovascular disease related to cancer treatment. This review summarises echocardiographic evaluation of cardiac dysfunction and heart failure as they are the most concerning cardiovascular complications of cancer therapy and worsen its morbidity and mortality. This review covers cardiac function assessment and proposed cut-off values before/during/after cancer chemotherapy. The goal of this review is to aid clinicians to manage the patients with cancer sufficiently by connecting the existing knowledge in clinical cardiology with novel information from current advances in cardio-oncology.

• Therapeutic Guidelines: Cardiovascular
• Chest Pain Evaluation
• CVD Calculator